Risk compensation after HIV-1 vaccination may accelerate viral adaptation and reduce cost-effectiveness: a modeling study
Kathryn Peebles, View ORCID ProfileJohn E. Mittler, View ORCID ProfileSteven M. Goodreau, View ORCID ProfileJames T. Murphy, Molly C. Reid, View ORCID ProfileNeil Abernethy, View ORCID ProfileGeoffrey S. Gottlieb, View ORCID ProfileRuanne V. Barnabas, View ORCID ProfileJoshua T. Herbeck
doi: https://doi.org/10.1101/2020.12.13.20248146
Kathryn Peebles
1Department of Epidemiology, University of Washington, Seattle, WA
John E. Mittler
2Department of Microbiology, University of Washington, Seattle, WA
Steven M. Goodreau
3Center for Studies in Demography and Ecology, University of Washington, Seattle, WA
4Department of Anthropology, University of Washington, Seattle, WA
James T. Murphy
5Department of Global Health, University of Washington, Seattle, WA
Molly C. Reid
1Department of Epidemiology, University of Washington, Seattle, WA
Neil Abernethy
6Department of Biomedical Inf. and Medical Education, University of Washington, Seattle, WA
7Department of Health Services, University of Washington, Seattle, WA
Geoffrey S. Gottlieb
8Department of Medicine, University of Washington, Seattle, WA
9Center for Emerging & Re-Emerging Infectious Diseases, University of Washington, Seattle, WA
Ruanne V. Barnabas
1Department of Epidemiology, University of Washington, Seattle, WA
5Department of Global Health, University of Washington, Seattle, WA
8Department of Medicine, University of Washington, Seattle, WA
10International Clinical Research Center, University of Washington, Seattle, WA
Joshua T. Herbeck
5Department of Global Health, University of Washington, Seattle, WA
10International Clinical Research Center, University of Washington, Seattle, WA
Data Availability
All model code is freely available on github.com/EvoNetHIV.
Posted December 14, 2020.
Risk compensation after HIV-1 vaccination may accelerate viral adaptation and reduce cost-effectiveness: a modeling study
Kathryn Peebles, John E. Mittler, Steven M. Goodreau, James T. Murphy, Molly C. Reid, Neil Abernethy, Geoffrey S. Gottlieb, Ruanne V. Barnabas, Joshua T. Herbeck
medRxiv 2020.12.13.20248146; doi: https://doi.org/10.1101/2020.12.13.20248146
Risk compensation after HIV-1 vaccination may accelerate viral adaptation and reduce cost-effectiveness: a modeling study
Kathryn Peebles, John E. Mittler, Steven M. Goodreau, James T. Murphy, Molly C. Reid, Neil Abernethy, Geoffrey S. Gottlieb, Ruanne V. Barnabas, Joshua T. Herbeck
medRxiv 2020.12.13.20248146; doi: https://doi.org/10.1101/2020.12.13.20248146
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11550)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3542)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (386)
- Neurology (3327)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (523)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (436)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5975)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)